The peptide reduces production of pro-inflammatory cytokines including IL-1, TNF-, and IL-6 while enhancing expression of anti-inflammatory mediators such as IL-10 and TGF-, creating a cytokine milieu that supports tissue repair rather than ongoing damage
doi: 10.1111/j.1365-2125.1988.tb03302.x
PMID 11071707
When patients begin weight loss treatment, multiple physiological changes occur simultaneously, and symptoms may arise from the weight loss process itself, dietary changes, increased physical activity, or coincidental factors rather than the medication directly
In clinical practice, even straightforward injectable treatments benefit from sterile technique, proper patient evaluation, and staff trained to recognize and manage adverse reactions